Northstar Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History

Northstar Wealth Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$350K	Sell	2,585 -42	-2%	-$5.7K	0.16%	105
2020 Q2	$359K	Sell	2,627 -2,888	-52%	-$368K	0.15%	126
2020 Q1	$594K	Buy	5,515 +843	+18%	+$97.1K	0.3%	85
2019 Q4	$563K	Sell	4,672 -1,000	-18%	-$112K	0.23%	104
2019 Q3	$564K	Sell	5,672 -390	-6%	-$40.8K	0.25%	102
2019 Q2	$661K	Hold	6,062	–	–	0.29%	94
2019 Q1	$678K	Hold	6,062	–	–	0.31%	88
2018 Q4	$585K	Hold	6,062	–	–	0.31%	90
2018 Q3	$739K	Buy	6,062 +651	+12%	+$76.7K	0.35%	83
2018 Q2	$594K	Sell	5,411 -28	-0.5%	-$3K	0.3%	97
2018 Q1	$580K	Buy	5,439 +1,606	+42%	+$178K	0.3%	99
2017 Q4	$415K	Sell	3,833 -289	-7%	-$30.9K	0.37%	81
2017 Q3	$466K	Sell	4,122 -591	-13%	-$63.2K	0.45%	73
2017 Q2	$486K	Sell	4,713 -552	-10%	-$54.4K	0.44%	73
2017 Q1	$504K	Buy	+5,265	New	+$504K	0.47%	68

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Northstar Wealth Partners's IBB Position: Q3 2020 in Review

Northstar Wealth Partners reduced its iShares Biotechnology ETF (IBB) stake by 1.6% in Q3 2020, selling an estimated $5.7K and leaving 2,585 shares worth $350K. The position accounts for 0.16% of the portfolio, ranked #105.

Northstar Wealth Partners first reported a position in IBB in Q1 2017 and has held it in 15 quarters since. The position peaked at $739K in Q3 2018. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

Northstar Wealth Partners held 2,585 shares of iShares Biotechnology ETF worth $350K as of Q3 2020.
Northstar Wealth Partners sold 42 iShares Biotechnology ETF shares in Q3 2020, an estimated $5.7K.
iShares Biotechnology ETF made up 0.16% of Northstar Wealth Partners's portfolio in Q3 2020, its #105 holding.
Northstar Wealth Partners first reported a position in iShares Biotechnology ETF in Q1 2017 and has held it in 15 quarters since.
Northstar Wealth Partners's iShares Biotechnology ETF position peaked at $739K in Q3 2018.
784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on Northstar Wealth Partners's 13F filing for Q3 2020, filed 13 Nov 2020.